Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Gross Profit (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Gross Profit for 15 consecutive years, with $24.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gross Profit rose 24.15% year-over-year to $24.4 million, compared with a TTM value of $94.0 million through Sep 2025, up 33.54%, and an annual FY2024 reading of $78.5 million, up 37.45% over the prior year.
  • Gross Profit was $24.4 million for Q3 2025 at Sanara MedTech, up from $23.9 million in the prior quarter.
  • Across five years, Gross Profit topped out at $24.4 million in Q3 2025 and bottomed at $4.5 million in Q1 2021.
  • Average Gross Profit over 5 years is $14.0 million, with a median of $13.6 million recorded in 2023.
  • The sharpest move saw Gross Profit skyrocketed 119.24% in 2021, then grew 22.82% in 2023.
  • Year by year, Gross Profit stood at $6.3 million in 2021, then skyrocketed by 107.13% to $12.9 million in 2022, then increased by 22.82% to $15.9 million in 2023, then skyrocketed by 51.28% to $24.1 million in 2024, then increased by 1.57% to $24.4 million in 2025.
  • Business Quant data shows Gross Profit for SMTI at $24.4 million in Q3 2025, $23.9 million in Q2 2025, and $21.6 million in Q1 2025.